|1 Table of Contents 3
|1.1 List of Tables 6
|1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Drug Delivery Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Drug Delivery Devices Market, Germany 11
3.1 Drug Delivery Devices Market, Germany, Revenue ($m), 2018-2033 11
3.2 Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2023 12
3.3 Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2023 13
3.4 Drug Delivery Devices Market, Germany, Revenue ($m), 2018-2033 14
3.5 Drug Delivery Devices Market, Germany, Volume (Units), 2018-2033 16
3.6 Drug Delivery Devices Market, Germany, Volume (Units), 2018-2033 17
3.7 Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), 2023 19
4 Central Venous Catheters Market, Germany 21
4.1 Central Venous Catheters Market, Germany, Revenue Mix ($m), 2023 21
4.2 Central Venous Catheters Market, Germany, Segment Contribution (%), 2023 22
4.3 Central Venous Catheters Market, Germany, Revenue ($m), 2018-2033 23
4.4 Central Venous Catheters Market, Germany, Volume (Units), 2018-2033 25
4.5 Central Venous Catheters Market, Germany, Average Price ($) , 2018-2033 27
4.6 Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), 2023 28
4.7 Central Venous Catheters Market, Germany, Company Share by Revenue ($m), 2023 29
5 Implantable Ports Market, Germany 30
5.1 Implantable Ports Market, Germany, Revenue Mix ($m), 2023 30
5.2 Implantable Ports Market, Germany, Segment Contribution (%), 2023 31
5.3 Implantable Ports Market, Germany, Revenue ($m), 2018-2033 32
5.4 Implantable Ports Market, Germany, Volume (Units), 2018-2033 34
5.5 Implantable Ports Market, Germany, Average Price ($) , 2018-2033 36
5.6 Implantable Ports Market, Germany, Distribution Share by Revenue ($m), 2023 37
5.7 Implantable Ports Market, Germany, Company Share by Revenue ($m), 2023 38
6 Infusion Systems Market, Germany 39
6.1 Infusion Systems Market, Germany, Revenue Mix ($m), 2023 39
6.2 Infusion Systems Market, Germany, Segment Contribution (%), 2023 40
6.3 Infusion Systems Market, Germany, Revenue ($m), 2018-2033 41
6.3.1 Infusion Pump Disposables Market, Germany, Revenue ($m), by Segment, 2018-2033 43
6.3.2 Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2018-2033 45
6.4 Infusion Systems Market, Germany, Volume (Units), 2018-2033 46
6.4.1 Infusion Pump Disposables Market, Germany, Volume (Units), by Segment, 2018-2033 48
6.4.2 Infusion Pumps Market, Germany, Volume (Units), by Segment, 2018-2033 50
6.5 Infusion Systems Market, Germany, Average Price ($) , 2018-2033 51
6.6 Infusion Systems Market, Germany, Distribution Share by Revenue ($m), 2023 52
6.7 Infusion Systems Market, Germany, Company Share by Revenue ($m), 2023 53
7 Overview of Key Companies in Germany, Drug Delivery Devices Market 54
7.1 B. Braun Melsungen AG 54
7.1.1 Company Overview 54
7.2 Becton Dickinson and Co 54
7.2.1 Company Overview 54
7.3 Teleflex Inc 54
7.3.1 Company Overview 54
7.4 Vygon SA 54
7.4.1 Company Overview 54
7.5 Edwards Lifesciences Corp 55
7.5.1 Company Overview 55
7.6 Baxter International Inc 55
7.6.1 Company Overview 55
7.7 ICU Medical Inc 55
7.7.1 Company Overview 55
7.8 Kimal plc 55
7.8.1 Company Overview 55
8 Drug Delivery Devices Market Pipeline Products 56
9 Financial Deals Landscape 64
9.1 Debt Offerings 64
9.1.1 Merck KGaA Raises USD890.2 Million in Public Offering of
3.875% Bonds Due 2054 64
9.2 Partnerships 65
9.2.1 Inventage Lab Enters into Co-Development Agreement with Boehringer Ingelheim 65
9.2.2 Aptar Pharma India Enters into Co-Development Agreement with Pulmotree Medical 66
9.3 Venture Financing 67
9.3.1 leon-Nanodrugs Raises Funds through series D Financing 67
10 Recent Developments 69
10.1 Corporate Communications 69
10.1.1 Jan 28, 2025: Resyca Receives Medical Device Regulation Certificate From TUV SUD 69
10.2 Financial Announcements 69
10.2.1 Aug 29, 2024: Schott Pharma Delivers Strong Third Quarter Results and Raises Fy 2024 Revenue Guidance 69
10.2.2 May 16, 2024: Johnson Electric Reports Results for the Year Ended 31 March 2024 71
10.3 Other Significant Developments 74
10.3.1 Jul 31, 2024: Hikma Pharmaceuticals: How Our Three Businesses Work Together to Improve Health 74
10.3.2 Jun 18, 2024: Advanced Robotic System Streamlines Syringe Processing 74
10.3.3 Jun 15, 2024: LTS to support Micron Biomedical as strategic CDMO partner to scale up Micron´s Microarray Patch technology 76
10.3.4 Jun 13, 2024: LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches 76
10.4 Product News 77
10.4.1 Mar 07, 2025: ImmunoGenesis doses first subject in Phase I/II trial of hypoxia reversal agent 77
10.4.2 Jan 13, 2025: Injection Moulding and Tubing Innovations also for the US Market 77
10.4.3 Oct 31, 2024: Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf 78
10.4.4 Aug 20, 2024: New Vector Vaccine Against COVID-19 Provides Long-Term Protection 78
10.4.5 Jul 31, 2024: Aenova Expert Article on Optimising the Pre-filled Syringe Filling Process 79
10.4.6 Jul 30, 2024: Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe 80
10.5 Strategy And Business Planning 80
10.5.1 Apr 10, 2025: Milestone for the Medical Care of Premature Babies Worldwide 80
10.5.2 Mar 11, 2025: Boehringer Ingelheim, Cognizant Launch Unified Cloud Platform 81
10.5.3 Feb 05, 2025: Recipharm Expands Aseptic Filling Capabilities for Process Development, Pilot Scale and Clinical Supply 81
10.5.4 Nov 07, 2024: BD and INS Partner to Elevate Standards of Infusion Care in MENAT 82
10.5.5 Sep 26, 2024: Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU” 82
10.5.6 Aug 15, 2024: Hoth Therapeutics and Aronnax Enter Master Services Agreement For HT-KIT Cancer Therapeutic 83
10.5.7 Jun 01, 2024: Boehringer Ingelheim's COPD and Asthma Inhalers Are Now Available for $35 a Month for Eligible Patients 83
11 Appendix 85
11.1 Research Methodology 86
11.1.1 Coverage 86
11.1.2 Secondary Research 86
11.1.3 Primary Research 87
11.1.4 Market Modeling and Forecasting 88
11.1.5 Company Share Analysis 89
11.1.6 Distribution Share Analysis 89
11.1.7 Benchmarking 90
11.2 GlobalData Consulting 90
11.3 Contact Us 90
11.4 Disclaimer 91